Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Let's summarize, shall we? Shocking, really. Less than a year ago IP was not in the running for a COVID therapeutic. Yet they did lab studies and published a paper and got FDA expedited approval and started a trial. All this from nothing at all.

And yet the share price is just above a quarter, and it is dropping steadily, for days now.

Is it all to be expected? A triple from 8-10 cents a share on the possibility that this would come to pass- that is plenty of gain for an unproven indication?

Maybe so. It shows how wrong the expectations were then, that there would a big rise in share price as these particulars unfolded. There were some bumps up, and then IP went right back down again.

Looking at it from a distance, this is about what we ought to have guessed since there is a good chance the trial will fail.

The long view helps understand how wrong expectations have been for this company. Over the top hopes? Those are still there, since maybe it helps patients. But a price of a quarter? Not many would have expected it at this juncture.

Interesting- I wrote this before seeing the trial news someone found today. Leo could not be bothered to tell us this himself. I wonder why? The trial is in Russia, with the fewest of exceptions? It just started and half the sites are not recruiting yet? How many enrolled? How many dosed? There is something sad about this when it ought to have been sensational.